| 5-HTP | 5-Hydroxitryptophan |
| ADHD | Attention Deficit Hyperactivity Disorder |
| ASD | Autism Spectrum Disorder |
| CSWRD | Circadian Sleep–Wake Rhythm Disorder |
| CSHQ | Children’s Sleep Habits Questionnaire |
| DLMO | Dim Light Melatonin Onset |
| DORAs | Dual Orexin Receptor Antagonists |
| EEG | Electroencephalographic |
| EMG | Electromyogram |
| FDA | U.S. Food and Drug Administration |
| FR | Fast Release |
| GABA | Gamma-aminobutyric acid |
| IDD | Intellectual Developmental Disorder |
| IQ | Intelligence Quotient |
| MT | Melatonin receptor |
| NDDs | Neurodevelopmental Disorders |
| NREM | Non-Rapid Eye Movement |
| ORAs | Orexin Receptor Antagonists |
| OXR | Orexin Receptor |
| PedPRM | Pediatric Prolonged Release Melatonin |
| PLMD | Periodic Limb Movement Disorder |
| RCTs | Randomized Controlled Trials |
| REM | Rapid Eye Movement |
| RLS | Restless Legs Syndrome |
| RSD | Restless Sleep Disorder |
| SE | Sleep Efficiency |
| SoL | Sleep onset Latency |
| SORAs | Selective Orexin Receptor Antagonists |
| SSP | Short Sensory Profile |
| SSRIs | Selective Serotonin Reuptake Inhibitors |
| SWA | Slow-Wave Activity |
| SWR | Sharp Wave Ripple |
| Trp | Tryptophan |
| TST | Total Sleep Time |
| UVB | Ultraviolet B |
| WASO | Wake After Sleep Onset |